These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 25816025

  • 1. Urinary CXCL1: a novel predictor of IgA nephropathy progression.
    Zhao Y, Zhu L, Zhou T, Zhang Q, Shi S, Liu L, Lv J, Zhang H.
    PLoS One; 2015; 10(3):e0119033. PubMed ID: 25816025
    [Abstract] [Full Text] [Related]

  • 2. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM.
    BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996
    [Abstract] [Full Text] [Related]

  • 3. Association between urinary C4d levels and disease progression in IgA nephropathy.
    Dong Y, Wang Z, Guo W, Zhu L, Zhou X, Shi S, Liu L, Lv J, Zhang H.
    Nephrol Dial Transplant; 2024 Jul 31; 39(8):1279-1287. PubMed ID: 38178632
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effect of mesangial cell-induced CXCL1 and TGF-β1 in promoting podocyte loss in IgA nephropathy.
    Zhu L, Zhang Q, Shi S, Liu L, Lv J, Zhang H.
    PLoS One; 2013 Jul 31; 8(8):e73425. PubMed ID: 24023680
    [Abstract] [Full Text] [Related]

  • 5. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
    Yang X, Ou J, Zhang H, Xu X, Zhu L, Li Q, Li J, Xie D, Sun J, Zha Y, Li Y, Tian J, Liu Y, Hou FF.
    Am J Kidney Dis; 2020 Mar 31; 75(3):384-393. PubMed ID: 31606236
    [Abstract] [Full Text] [Related]

  • 6. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy.
    Liu LL, Jiang Y, Wang LN, Liu N.
    Clin Exp Immunol; 2012 Aug 31; 169(2):148-55. PubMed ID: 22774989
    [Abstract] [Full Text] [Related]

  • 7. Significance of urinary full-length megalin in patients with IgA nephropathy.
    Seki T, Asanuma K, Asao R, Nonaka K, Sasaki Y, Oliva Trejo JA, Kurosawa H, Hirayama Y, Horikoshi S, Tomino Y, Saito A.
    PLoS One; 2014 Aug 31; 9(12):e114400. PubMed ID: 25502002
    [Abstract] [Full Text] [Related]

  • 8. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity.
    Xu PC, Zhang JJ, Chen M, Lv JC, Liu G, Zou WZ, Zhang H, Zhao MH.
    Nephrol Dial Transplant; 2011 Oct 31; 26(10):3229-36. PubMed ID: 21402675
    [Abstract] [Full Text] [Related]

  • 9. Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.
    Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG.
    Korean J Intern Med; 2014 May 31; 29(3):334-40. PubMed ID: 24851068
    [Abstract] [Full Text] [Related]

  • 10. Implication of urinary complement factor H in the progression of immunoglobulin A nephropathy.
    Liu M, Chen Y, Zhou J, Liu Y, Wang F, Shi S, Zhao Y, Wang S, Liu L, Lv J, Zhang H, Zhao M.
    PLoS One; 2015 May 31; 10(6):e0126812. PubMed ID: 26035554
    [Abstract] [Full Text] [Related]

  • 11. Urinary Biomarkers in the Prediction of Prognosis and Treatment Response in IgA Nephropathy.
    Neuhaus J, Bauer F, Fitzner C, Hilgers RD, Seibert F, Babel N, Doevelaar A, Eitner F, Floege J, Rauen T, Westhoff TH.
    Kidney Blood Press Res; 2018 May 31; 43(5):1563-1572. PubMed ID: 30347407
    [Abstract] [Full Text] [Related]

  • 12. Clinical features and natural history of IgA nephropathy.
    Rychlik I, Andrassy K, Waldherr R, Zuna I, Tesar V, Jancová E, Stejskalová A, Ritz E.
    Ann Med Interne (Paris); 1999 Feb 31; 150(2):117-26. PubMed ID: 10392260
    [Abstract] [Full Text] [Related]

  • 13. Urinary angiostatin: a novel biomarker of kidney disease associated with disease severity and progression.
    Xia YY, Bu R, Cai GY, Zhang XG, Duan SW, Wu J, Wu D, Chen XM.
    BMC Nephrol; 2019 Apr 03; 20(1):118. PubMed ID: 30943905
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Proteinuria in the prognosis of IgA nephropathy.
    Aucella F, Netti GS, Piemontese M, Cincione IR, Infante B, Gesualdo L.
    Minerva Urol Nefrol; 2009 Sep 03; 61(3):235-48. PubMed ID: 19773725
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. TWEAK/Fn14 system and crescent formation in IgA nephropathy.
    Sasaki Y, Shimizu Y, Suzuki Y, Horikoshi S, Tomino Y.
    BMC Nephrol; 2015 Mar 14; 16():27. PubMed ID: 25885587
    [Abstract] [Full Text] [Related]

  • 18. A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN).
    Yamamoto R, Nagasawa Y, Shoji T, Inoue K, Uehata T, Kaneko T, Okada T, Yamauchi A, Tsubakihara Y, Imai E, Isaka Y, Rakugi H.
    Nephrol Dial Transplant; 2009 Dec 14; 24(12):3686-94. PubMed ID: 19420105
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for pregnancy outcomes in patients with IgA nephropathy: a matched cohort study.
    Liu Y, Ma X, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Am J Kidney Dis; 2014 Nov 14; 64(5):730-6. PubMed ID: 25134778
    [Abstract] [Full Text] [Related]

  • 20. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S, Lundahl J, Gunnarsson I, Sundelin B, Jacobson SH.
    Nephrol Dial Transplant; 2012 May 14; 27(5):1916-23. PubMed ID: 21940483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.